Xontogeny

Biotechnology · Venture Capital
1,137open roles in its portfolio
28investments
6exits
2016founded

Overview

Xontogeny is a life sciences accelerator and seed-stage investor that helps scientific founders and first-time CEOs build drug development companies. It provides seed and Series A funding together with hands-on strategic and operational support, investing alongside the Perceptive Xontogeny Venture Fund backed by Perceptive Advisors. The company was founded in 2016 by biotech executive Chris Garabedian and is based in Boston, Massachusetts.

Program

Accelerator
Investments
28
17 of them startups
Hiring now
8
1,137 open roles
Exits
6
Focusshare of its companies
Health Care 71%Biotechnology 24%Financial Services 6%Artificial Intelligence 6%Sports 6%Gaming 6%
Where its companies are
United States 54%
Stage of its companies
Pre-seed & seed 100%

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
361 Newbury Street, Suite 501, Boston, MA, 02115, US
company site